ENYO Pharma

ENYO Pharma

Biotechnology Research Lyon, Rhône, Fr 38 employees
Employees
38
Contacts
3
Emails
3

ENYO Pharma Overview

Headquarters
Lyon, Rhône, Fr
Phone Number
Available in AeroLeads
Website
enyopharma.com
Industry
Biotechnology Research
Employees
38
Founded
2014
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ENYO Pharma

ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor.

ENYO Pharma Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

ENYO Pharma Org Chart

Sample employees and titles
Name Title Contact
Iain Dukes Venture Partner at Orbimed
Email
Virginie Vidal Head of Clinical Operations at Enyo Pharma
Email
Pietro Scalfaro Physician, Life Sciences & E-health Executive
View
Carole Dubreuil Head of the CEO Project Office🔹scientist🔹science Communicator and Popularizer
Email

Employees by Management Level

Individual contributor 10 profiles
Executive 1 profile
VP / Head 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
Executive 1 1 0

ENYO Pharma Tech Stack

Engineering 2 profiles
Data / AI 1 profile

Compare Similar Companies to ENYO Pharma